Nintedanib esylate hemihydrate is a medication mainly used to treat idiopathic pulmonary fibrosis (IPF), a condition that causes progressive scarring of the lungs. It is also used in certain cases of chronic fibrosing interstitial lung diseases and systemic sclerosis-associated interstitial lung disease. Nintedanib works as a tyrosine kinase inhibitor, targeting multiple pathways involved in fibrosis and inflammation, thereby slowing the progression of lung damage. It is grouped under the following drug class(es): Tyrosine Kinase Inhibitors and VEGF inhibitors. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include 1H-Indole-6-carboxylic acid, 2, 3-dihydro-3-(((4-(methyl(2-(4-methyl-1-piperazinyl)acetyl)amino)phenyl)amino)phenylmethylene)-2-oxo-, methyl ester, (3Z)-, methanesulfonate and hydrate (2:2:1). Its PubChem CID is 162625094.
Nintedanib esylate hemihydrate
| CAS No | 959762-24-4 |
|---|---|
| Molecular Formula | C66H80N10O15S2 |
| Molecular Weight | 1317.5 g/mol |
| Synonyms | ethanesulfonic acid;methyl 2-hydroxy-3-[N-[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]phenyl]-C-phenylcarbonimidoyl]-1H-indole-6-carboxylate;hydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Nintedanib esylate hemihydrate is a medication mainly used to treat idiopathic pulmonary fibrosis (IPF), a condition that causes progressive scarring of the lungs.
The listed CAS number is 959762-24-4.
The listed molecular formula is C66H80N10O15S2.
The listed molecular weight is 1317.5 g/mol.
ethanesulfonic acid;methyl 2-hydroxy-3-[N-[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]phenyl]-C-phenylcarbonimidoyl]-1H-indole-6-carboxylate;hydrate.
The source lists 1H-Indole-6-carboxylic acid, 2, 3-dihydro-3-(((4-(methyl(2-(4-methyl-1-piperazinyl)acetyl)amino)phenyl)amino)phenylmethylene)-2-oxo-, methyl ester, (3Z)-, methanesulfonate and hydrate (2:2:1).